<?xml version='1.0' encoding='utf-8'?>
<document id="28911598"><sentence text="Correlation between drug-drug interaction-induced Stevens-Johnson syndrome and related deaths in Taiwan." /><sentence text="Concomitant use of some drugs can lead to interactions between them resulting in severe adverse effects" /><sentence text=" To date, there are few reports of incidences of Stevens-Johnson syndrome (SJS) associated with combination drug administration" /><sentence text=" Therefore, we studied the relationship between drug combinations and SJS-related mortality, with the hope that a retrospective study of this nature would provide information crucial for the prevention of future drug-drug interaction related deaths attributable to SJS" /><sentence text=" This retrospective longitudinal study used mortality cases from 1999 to 2008 that were diagnosed as erythema multiforme (International Classification of Diseases, Ninth Revision, Clinical Modification 695" /><sentence text="1) from the National Health Insurance database in Taiwan" /><sentence text=" Statistical comparisons of the results were performed using analysis of variance (ANOVA), independent sample t-tests, and odds ratio (OR)" /><sentence text=" In this way, the relationship between combinations of SJS-inducing drugs and mortality could be determined" /><sentence text=" A total of 111 patients who had died, including 63 males and 48 females (66" /><sentence text="0 ± 20 and 70" /><sentence text="0 ± 17" /><sentence text="7 years, respectively), were suspected of having experienced drug-drug interaction-related adverse effects" /><sentence text=" The associated drug combinations included allopurinol and ampicillin (p = 0"><entity charOffset="43-54" id="DDI-PubMed.28911598.s13.e0" text="allopurinol" /><entity charOffset="59-69" id="DDI-PubMed.28911598.s13.e1" text="ampicillin" /><pair ddi="false" e1="DDI-PubMed.28911598.s13.e0" e2="DDI-PubMed.28911598.s13.e0" /><pair ddi="false" e1="DDI-PubMed.28911598.s13.e0" e2="DDI-PubMed.28911598.s13.e1" /></sentence><sentence text="049), carbamazepine and sulfamethoxazole/trimethoprim (TMP) (p &lt; 0"><entity charOffset="6-19" id="DDI-PubMed.28911598.s14.e0" text="carbamazepine" /><entity charOffset="24-40" id="DDI-PubMed.28911598.s14.e1" text="sulfamethoxazole" /><entity charOffset="41-53" id="DDI-PubMed.28911598.s14.e2" text="trimethoprim" /><entity charOffset="55-58" id="DDI-PubMed.28911598.s14.e3" text="TMP" /><pair ddi="false" e1="DDI-PubMed.28911598.s14.e0" e2="DDI-PubMed.28911598.s14.e0" /><pair ddi="false" e1="DDI-PubMed.28911598.s14.e0" e2="DDI-PubMed.28911598.s14.e1" /><pair ddi="false" e1="DDI-PubMed.28911598.s14.e0" e2="DDI-PubMed.28911598.s14.e2" /><pair ddi="false" e1="DDI-PubMed.28911598.s14.e0" e2="DDI-PubMed.28911598.s14.e3" /><pair ddi="false" e1="DDI-PubMed.28911598.s14.e1" e2="DDI-PubMed.28911598.s14.e1" /><pair ddi="false" e1="DDI-PubMed.28911598.s14.e1" e2="DDI-PubMed.28911598.s14.e2" /><pair ddi="false" e1="DDI-PubMed.28911598.s14.e1" e2="DDI-PubMed.28911598.s14.e3" /><pair ddi="false" e1="DDI-PubMed.28911598.s14.e2" e2="DDI-PubMed.28911598.s14.e2" /><pair ddi="false" e1="DDI-PubMed.28911598.s14.e2" e2="DDI-PubMed.28911598.s14.e3" /></sentence><sentence text="0001), carbamazepine and phenytoin (p &lt; 0"><entity charOffset="7-20" id="DDI-PubMed.28911598.s15.e0" text="carbamazepine" /><entity charOffset="25-34" id="DDI-PubMed.28911598.s15.e1" text="phenytoin" /><pair ddi="false" e1="DDI-PubMed.28911598.s15.e0" e2="DDI-PubMed.28911598.s15.e0" /><pair ddi="false" e1="DDI-PubMed.28911598.s15.e0" e2="DDI-PubMed.28911598.s15.e1" /></sentence><sentence text="0001), sulfamethoxazole/TMP and phenytoin (p = 0"><entity charOffset="7-23" id="DDI-PubMed.28911598.s16.e0" text="sulfamethoxazole" /><entity charOffset="24-27" id="DDI-PubMed.28911598.s16.e1" text="TMP" /><entity charOffset="32-41" id="DDI-PubMed.28911598.s16.e2" text="phenytoin" /><pair ddi="false" e1="DDI-PubMed.28911598.s16.e0" e2="DDI-PubMed.28911598.s16.e0" /><pair ddi="false" e1="DDI-PubMed.28911598.s16.e0" e2="DDI-PubMed.28911598.s16.e1" /><pair ddi="false" e1="DDI-PubMed.28911598.s16.e0" e2="DDI-PubMed.28911598.s16.e2" /><pair ddi="false" e1="DDI-PubMed.28911598.s16.e1" e2="DDI-PubMed.28911598.s16.e1" /><pair ddi="false" e1="DDI-PubMed.28911598.s16.e1" e2="DDI-PubMed.28911598.s16.e2" /></sentence><sentence text="015), sulfadoxine and piroxicam (p = 0"><entity charOffset="6-17" id="DDI-PubMed.28911598.s17.e0" text="sulfadoxine" /><entity charOffset="22-31" id="DDI-PubMed.28911598.s17.e1" text="piroxicam" /><pair ddi="false" e1="DDI-PubMed.28911598.s17.e0" e2="DDI-PubMed.28911598.s17.e0" /><pair ddi="false" e1="DDI-PubMed.28911598.s17.e0" e2="DDI-PubMed.28911598.s17.e1" /></sentence><sentence text="045), phenobarbital and cephalexin (p &lt; 0"><entity charOffset="24-34" id="DDI-PubMed.28911598.s18.e0" text="cephalexin" /></sentence><sentence text="0001), ampicillin and erythromycin (p &lt; 0"><entity charOffset="7-17" id="DDI-PubMed.28911598.s19.e0" text="ampicillin" /><entity charOffset="22-34" id="DDI-PubMed.28911598.s19.e1" text="erythromycin" /><pair ddi="false" e1="DDI-PubMed.28911598.s19.e0" e2="DDI-PubMed.28911598.s19.e0" /><pair ddi="false" e1="DDI-PubMed.28911598.s19.e0" e2="DDI-PubMed.28911598.s19.e1" /></sentence><sentence text="0001), erythromycin and minocycline (p &lt; 0"><entity charOffset="7-19" id="DDI-PubMed.28911598.s20.e0" text="erythromycin" /><entity charOffset="24-35" id="DDI-PubMed.28911598.s20.e1" text="minocycline" /><pair ddi="false" e1="DDI-PubMed.28911598.s20.e0" e2="DDI-PubMed.28911598.s20.e0" /><pair ddi="false" e1="DDI-PubMed.28911598.s20.e0" e2="DDI-PubMed.28911598.s20.e1" /></sentence><sentence text="0001), and vancomycin and ethambutol (p &lt; 0"><entity charOffset="11-21" id="DDI-PubMed.28911598.s21.e0" text="vancomycin" /><entity charOffset="26-36" id="DDI-PubMed.28911598.s21.e1" text="ethambutol" /><pair ddi="false" e1="DDI-PubMed.28911598.s21.e0" e2="DDI-PubMed.28911598.s21.e0" /><pair ddi="false" e1="DDI-PubMed.28911598.s21.e0" e2="DDI-PubMed.28911598.s21.e1" /></sentence><sentence text="0001) administered 1 month before the patients' deaths" /><sentence text=" Caution should be exercised when administering any drugs that may possibly induce SJS" /><sentence text=" In addition, attention should be paid to ensure prompt identification of possible drug-drug interactions, and patients should be closely monitored" /><sentence text=" Furthermore, medications should be immediately discontinued at the first sign or symptom suggesting the occurrence of drug-related SJS, and then prompt, adequate supportive care should be provided" /><sentence text="" /></document>